8 Related guidance
8.1 NICE has issued the following related guidance.
Improving outcomes in urological cancers. NICE cancer service guidance (2002).
Prostate cancer: diagnosis and treatment of prostate cancer. NICE clinical guideline 58 (2008).
8.2 NICE is in the process of developing the following guidance (details available from the NICE website).
Atrasentan for hormone-refractory prostate cancer. NICE technology appraisal guidance (suspended).